XML 44 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of restricted stock unit activities
   Restricted Stock Units   Weighted
Average Grant
Date Fair Value
 
Non-vested 1/1/2020   -   $- 
Granted   479,325    29.97 
Forfeited   (56,375)   30.00 
Vested   (148,334)   30.00 
Non-vested 12/31/2020   274,616   $29.95 
Schedule of the fair value of stock options granted
  For the Years Ended
December 31,
    2020   2019
Stock price   $ 17.84 - $ 51.12   $ 6.81 - $ 8.65
Exercise price   $ 17.84 - $ 51.12   $ 9.18
Dividend yield   0.00%   0.00%
Expected volatility   95.00% - 101.00%   97.00%
Risk-free interest rate   0.28% - 1.69%   1.71% - 2.37%
Expected life (in years)   5.27 - 6.08   5.58 - 6.02
Schedule of stock option activities
   Options   Weighted Average Grant Date Fair Value   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (years)   Aggregate Intrinsic Value 
Outstanding 1/1/2020   219,592   $7.29   $9.18    9.72   $- 
Granted   565,100    22.61    29.23    -    - 
Exercised   (57,767)   6.72    9.18    -    - 
Forfeited   (52,886)   14.08    18.91    -    - 
Outstanding 12/31/2020   674,039   $20.60   $25.23    9.06   $2,311 
                          
Exercisable as of 12/31/2020   109,117   $11.44   $15.63    8.25   $1,201
Schedule of total stock-based compensation costs
   For the Years Ended
December 31,
 
   2020   2019 
Restricted stock  $-   $75 
RSUs   6,357    36 
Stock options   3,389    313 
Total  $9,746   $424
Schedule of stock based compensation expense
   For the Years Ended
December 31,
 
   2020   2019 
Research and development  $741   $200 
General and administrative   9,005    224 
Total  $9,746   $424